President Donald Trump announced a groundbreaking deal on Thursday with EMD Serono, a subsidiary of German pharmaceutical giant Merck KGaA, designed to significantly reduce out-of-pocket expenses for in vitro fertilization (IVF). This initiative marks a major step toward making fertility treatments more affordable for families across the country. The announcement comes more than a year after Trump’s campaign promise to eliminate all costs associated with IVF, highlighting his administration’s commitment to improving access to reproductive healthcare.
Trump rolls out his latest deal with a drugmaker. This one stems from his campaign promise to cover all IVF costs.
Share
Read more